Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)

Masato Kataoka, Mitsuro Kanda, Kiyoshi Ishigure, Hiroshi Matsuoka, Yusuke Sato, Takao Takahashi, Chihiro Tanaka, Tomohiro Deguchi, Yoshihisa Shibata, Mikinori Sato, Hitoshi Inagaki, Takanori Matsui, Akinobu Kondo, Nao Takano, Haruyoshi Tanaka, Junichi Sakamoto, Koji Oba, Ken Kondo

Research output: Contribution to journalComment/debate

Abstract

Akinobu Kondo’s first name is incorrect in the original article. It is corrected as shown in this erratum. Also, the following Acknowledgment was inadvertently omitted: Acknowledgment This study was supported, in part, by the nonprofit organization Epidemiological and Clinical Research Information Network (ECRIN).

Original languageEnglish
Number of pages1
JournalAnnals of Surgical Oncology
Volume23
DOIs
Publication statusPublished - 01-12-2016

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)'. Together they form a unique fingerprint.

  • Cite this